Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending May 06, 2005. The report details a share repurchase transaction executed on May 05, 2005, and updates regarding directors' interests in company shares.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margins, debt, or liquidity figures. It focuses exclusively on capital structure changes and share ownership details.
- Shares Repurchased: 745,000 Ordinary shares.
- Repurchase Price: 1,342.69 pence per share.
- Treasury Shares Held: 86,338,000 shares (post-transaction).
- Shares in Issue: 5,854,971,362 shares (excluding Treasury shares).
Material Changes
The primary material change is the reduction of outstanding shares through a buyback authorized by shareholders at the Annual General Meeting on May 17, 2004. Additionally, the GlaxoSmithKline Employee Trust transferred 20,090 Ordinary Shares to participants in the SmithKline Beecham Employee Share Option Plan 1991.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, management commentary on operations, or discussion of risks and contingencies. It explicitly states that the announcement does not constitute an offer or solicitation to purchase securities.
Investor Verification Points
- Verify the total cost of the 745,000 share repurchase against the stated price of 1,342.69 pence.
- Confirm the updated total share count (5,854,971,362 in issue) against subsequent filings.
- Review the impact of the 20,090 shares transferred from the GSK Trust on the Employee Share Option Plan 1991.